Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results 2023-11-30 14:00
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort 2023-11-29 21:58
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device 2023-11-29 21:00
Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award 2023-11-28 21:30
Akeso Launches Construction of Shanghai Global R&D Center to Accelerate Its Innovation Globalization Strategy 2023-11-28 21:00
Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients 2023-11-27 21:30
Ascentage Pharma Hosts Ceremony Marking the Launch of Olverembatinib in Newly Approved Indication and the Dispatch of First Batch for the New Indication 2023-11-24 19:57
China's First NDA for a KRAS G12C Inhibitor: NMPA Accepts New Drug Application for GFH925 and Grants GFH925 with Priority Review Designation 2023-11-24 19:00
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome 2023-11-23 10:31
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale 2023-11-22 13:21
ST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop 2023-11-21 12:00
Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging 2023-11-20 20:00
First Subject Enrolled in Phase 1 Study of MRX-5 2023-11-20 18:34
Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery. 2023-11-18 08:00
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update 2023-11-17 22:21
Taiwan Lubricate for academic research and health products development 2023-11-17 20:00
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement 2023-11-17 16:00
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange 2023-11-17 14:00
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial 2023-11-16 22:00
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing 2023-11-16 20:08
1 31 32 33 34 35 165